Heron Therapeutics, Inc. (HRTX) Social Stream
HERON THERAPEUTICS INC (HRTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering HRTX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-10 | 3 | $60 | $23 | $33 | $2.155 | 1431.32% |
| 2022-03-01 | 4 | $60 | $23 | $33 | $2.155 | 1431.32% |
| 2022-03-02 | 4 | $60 | $13 | $27.2 | $2.155 | 1162.18% |
| 2022-05-10 | 4 | $60 | $12 | $22.8 | $2.155 | 958% |
| 2022-05-11 | 4 | $60 | $7.5 | $21.7 | $2.155 | 906.96% |
| 2022-08-09 | 5 | $60 | $7.5 | $18.75 | $2.155 | 770.07% |
| 2022-09-20 | 5 | $14 | $5.5 | $10.1 | $2.155 | 368.68% |
| 2022-11-09 | 5 | $13 | $5.5 | $9.5 | $2.155 | 340.84% |
| 2023-01-19 | 5 | $13 | $5.5 | $9.1 | $2.155 | 322.27% |
| 2023-03-27 | 5 | $13 | $5.5 | $9.1 | $2.155 | 322.27% |
| 2023-05-15 | 5 | $9 | $5.5 | $6.875 | $2.155 | 219.03% |
| 2023-07-10 | 5 | $10.001 | $5.5 | $7.5 | $2.155 | 248.03% |
| 2023-07-24 | 5 | $10 | $5.5 | $7.5 | $2.155 | 248.03% |
| 2023-08-16 | 5 | $10 | $5 | $7.3 | $2.155 | 238.75% |
| 2023-11-15 | 5 | $9 | $5 | $6.625 | $2.155 | 207.42% |
| 2023-11-16 | 4 | $9 | $2.5 | $5.625 | $2.155 | 161.02% |
The Trend in the Analyst Price Target
Over the past 42 months, HRTX's average price target has gone down $32.67.
HRTX reports an average of 398.87% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-28 | 5 | 10 | 5.5 | 7.700 | 1.61 | 378.26% |
| 2023-05-11 | 5 | 10 | 5.5 | 7.700 | 2.23 | 245.29% |
| 2023-05-15 | 5 | 9 | 5.5 | 6.875 | 1.33 | 416.92% |
| 2023-07-24 | 5 | 10 | 5.5 | 7.500 | 1.54 | 387.01% |
| 2023-11-15 | 5 | 9 | 5.0 | 6.625 | 0.86 | 670.35% |
HRTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 3 | 1 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
HRTX's average broker recommendation rating improved by 0 over the prior 17 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HRTX as an investment opportunity.
- In terms of how HERON THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1749.69% of that group.
- HERON THERAPEUTICS INC's variance in analysts' estimates is lower than -1501.05% of all US stocks.
- In the context of all US stocks, HERON THERAPEUTICS INC's average analyst price target is greater than 319.19% of them.
- In the context of stocks in the mid market cap category, HERON THERAPEUTICS INC's number of analysts covering the stock is higher than 323.62% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to HERON THERAPEUTICS INC are ADCT, CERE, and NUVB.
View All Top Stocks by Price Target
Is HRTX a Buy, Hold or Sell? See the POWR Ratings now!